scholarly journals A Unique Opportunity for an Intercultural Discussion on CAM and Liver Disease

2005 ◽  
Vol 2 (2) ◽  
pp. 253-254
Author(s):  
Francesco Marotta

The meeting of the APASL, Asian Pacific Association for the Study of the Liver, was held in December 2004, in New Delhi, India. The meeting was held under the patronage of the APASL Committee and Board of Presidents of the National Liver Association and in conjunction with the annual conference of the Indian Association for the Study of Liver (INASL). The congress was designed to have a core meeting with three parallel sessions running throughout, dedicated research workshops and intensive breakfast sessions. This report concentrates on the two sessions devoted to complementary and alternative medicine (CAM) and shows the latest research in CAM for liver disease and the concerns of doctors about integrating CAM with more traditional treatments. With researchers and practitioners gathering from all over the world, it was a unique opportunity for an intercultural discussion on CAM and liver disease.

2002 ◽  
Vol 97 (9) ◽  
pp. 2391-2397 ◽  
Author(s):  
Doris B. Strader ◽  
Bruce R. Bacon ◽  
Karen L. Lindsay ◽  
Douglas R. Brecque ◽  
Timothy Morgan ◽  
...  

2010 ◽  
Vol 44 (2) ◽  
pp. e40-e45 ◽  
Author(s):  
Leah M. Ferrucci ◽  
Beth P. Bell ◽  
Kathy B. Dhotre ◽  
M. Michele Manos ◽  
Norah A. Terrault ◽  
...  

2006 ◽  
Vol 21 (3) ◽  
pp. 255-272 ◽  
Author(s):  
A. James Hanje ◽  
Brett Fortune ◽  
Ming Song ◽  
Daniell Hill ◽  
Craig McClain

2007 ◽  
Vol 21 (9) ◽  
pp. 589-595 ◽  
Author(s):  
Colin P White ◽  
Gerilynn Hirsch ◽  
Sunil Patel ◽  
Fatin Adams ◽  
Kevork M Peltekian

Complementary and alternative medicine (CAM) is becoming increasingly popular in North America. The use of CAM is also popular in patients with chronic liver disease but is not well documented. The extent of use of CAM in chronic hepatitis C virus (HCV) infected patients was determined, and the demographic and clinical data between users and nonusers of CAM was compared.Seventy-six patients (30% female) with chronic HCV were interviewed. The mean age was 43±8 years. Current use of CAM for HCV was reported by 35 of 76 patients (46%). Eighteen of 76 patients within this group used herbal supplements (24%). The most commonly used herb wasSilybum marianum(milk thistle), reported by 10 of 76 patients (13.2%). Commonly reported benefits of CAM use included reduction in fatigue, boost in the immune system and improved gastrointestinal function. No adverse effects of CAM use were reported. In the present study, four of 18 patients (22%) with chronic liver disease taking herbal therapies were on herbs that increased bleeding time.The use of CAM in chronic HCV patients is significant. Patients should be asked specifically about their use of CAM. CAM use may have implications affecting conventional treatment and management of HCV.


Sign in / Sign up

Export Citation Format

Share Document